authors
- Vansant, JP
- Divine, RW
- Begani, PM
- Berry, RP
- Seligman, M
- Weresch, Justin
- Ey, FS
Initial experience with yttrium 90 ibritumomab tiuxetan (Zevalin®):: A model for successful implementation of radioimmunotherapy (RIT) in the community setting.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 16, 2003
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Immunology (Science Metrix)
published in
- Blood Journal